Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for CBAN yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $19.41 | $19.27 | -0.72% | 0.1M |
| 05-18 | $19.37 | $19.47 | +0.52% | 0.2M |
| 05-19 | $19.45 | $19.38 | -0.36% | 0.1M |
| 05-20 | $19.45 | $19.72 | +1.39% | 0.2M |
| 05-21 | $19.66 | $19.79 | +0.66% | 0.4M |
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $44.89M | $35.52M | $109.25M | $72.36M |
Operating Income | $10.47M | $8.28M | $25.58M | $18.30M |
Net Income | $8.20M | $6.61M | $20.41M | $14.59M |
EPS (Diluted) | $0.39 | $0.38 | $1.17 | $0.83 |
Total Assets | $3.72B | $3.74B | $3.15B | $3.12B |
Total Liabilities | $3.34B | $3.36B | $2.85B | $2.82B |
Cash & Equivalents | $295.81M | $257.64M | $199.97M | $112.14M |
Free Cash Flow OCF − CapEx | $53.83M | $-6.90M | $47.42M | $33.36M |
Shares Outstanding | 21.16M | 21.25M | 17.46M | 17.42M |
CBAN is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.